Marco Boorsma
InvestorGeneral Partner at Forbion
Amsterdam, Netherlands
Writes $100K – $5M checks · typically $1.5M
About
Marco Boorsma is a General Partner at Forbion, which he joined in 2007. Before Forbion, he was Business Development Director at DSM Pharmaceutical Products and worked on manufacturing processes for biosimilars at Cytos Biotechnology. He focuses on biotechnology, operations, and business development, with an emphasis on founding and managing new companies as part of Forbion's build strategy, and holds an MSc in Molecular Biology from the University of Groningen and a PhD in Biotechnology from ETH Zürich.
Invests in
Biotech
Experience
- ForbionGeneral Partnercurrent2017 — presentNaarden, The Netherlands
- ForbionPartner2014 — 2017Naarden, The Netherlands
- ForbionPrincipal2010 — 2014
- ForbionSenior Analyst2007 — 2010Naarden
- Calluna PharmaBoard Director at Calluna Pharmacurrent2024 — presentOslo, Norway
- Sitala BioBoard Director at Sitalacurrent2021 — presentCambridge, England, United Kingdom
- Rectify PharmaBoard Director at Rectify Pharmacurrent2021 — presentCambridge, Massachusetts, United States
- VectorYBoard Director at VectorY2021 — 2025Amsterdam, North Holland, Netherlands
- VectorYChief Executive Officer2020 — 2021Amsterdam, North Holland, Netherlands
- Oxitope PharmaChairman of the Board2020 — 2023Naarden, North Holland, Netherlands
- Engene Inc.Board Director at enGene2017 — 2023Montreal, Canada
- Inversago PharmaBoard Director at Inversago2020 — 2023Montreal, Quebec, Canada
- Escalier Biosciences B.V.Board Director at Escalier Biosciences2018 — 2023Nijmegen, The Netherlands
- Inflazome LtdBoard Director at Inflazome2018 — 2020Dubline, Ireland
- NorthSea TherapeuticBoard Director at NorthSea Therapeutics2017 — 2019Naarden, The Netherlands
- Milestone Pharmaceuticals, Inc.Board Director at Milestone Pharmaceuticals2017 — 2019Greater Montreal Metropolitan Area
- Exosome DiagnosticsObserver to the BoD2010 — 2018Cambridge, USA
- Prexton Therapeutics SABoard Director at Prexton Therapeutics2017 — 2018Netherlands
- RSPR Pharma ABBoard Director at RSPR Pharma2014 — 2018Greater Stockholm Metropolitan Area
- OxyraneObserver to the BoD2011 — 2017Manchester Area, United Kingdom
Education
- ETH ZürichPhD, Biotechnology1998 — 2001
- University of GroningenBS, Molecular Biology1993 — 1998
Skills & more
+12 more
R&DPharmaceutical IndustryDrug DevelopmentStart-upsPatentsIntellectual PropertyVaccinesValidationEntrepreneurshipImmunologyMergers & AcquisitionsMedical DevicesFrom Marco's professional profile.
Deals · 1
Milestone PharmaceuticalsBoard seat
via Forbion · filed Jul 2017 · $6.9M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Forbion
Network1
Investors connected to Marco in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Marco Boorsma work?
- Marco Boorsma is General Partner at Forbion.
- What does Marco Boorsma invest in?
- Marco Boorsma invests in Biotech.
- What check size does Marco Boorsma write?
- Marco Boorsma typically writes checks of $100K – $5M.
Same school
Also attended ETH Zürich210
+ 204 more
Also attended University of Groningen135
+ 129 more
Shared employers
Also worked at Calluna Pharma2
Also worked at Engene Inc.4
Also worked at DSM Pharmaceutical Products20
+ 14 more





































